John N. Bonfiglio
No más puestos en curso
Historial de carrera de John N. Bonfiglio
Antiguos cargos conocidos de John N. Bonfiglio.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| QRONS INC. | Director de Operaciones | 01/07/2019 | 30/11/2019 |
| GENPREX, INC. | Director/Miembro de la Junta | 12/02/2019 | 10/06/2019 |
| GT BIOPHARMA, INC. | Director/Miembro de la Junta | 03/07/2018 | 20/03/2019 |
| MARKER THERAPEUTICS, INC. | Director/Miembro de la Junta | 23/07/2015 | 27/04/2017 |
| Director de Operaciones | 18/07/2016 | 27/04/2017 | |
| Presidente | 18/07/2016 | 27/04/2017 | |
| ORAGENICS, INC. | Director/Miembro de la Junta | 25/05/2011 | 30/10/2014 |
| Director Ejecutivo | 25/05/2011 | 30/10/2014 | |
| Presidente | 25/05/2011 | 30/10/2014 | |
| HARROW, INC. | Director/Miembro de la Junta | 22/10/2010 | 13/05/2011 |
| Director Ejecutivo | 18/10/2010 | 13/05/2011 | |
| Presidente | 22/10/2010 | 13/05/2011 | |
| ARGOS THERAPEUTICS, INC. | Director Ejecutivo | 01/12/2006 | 23/02/2010 |
| Presidente | 01/12/2006 | 23/02/2010 | |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Director Ejecutivo | 01/01/2003 | 31/10/2005 |
| Presidente | 01/01/2003 | 31/10/2005 | |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Director de Operaciones | 01/01/2001 | - |
| ░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formación de John N. Bonfiglio.
| Pepperdine University | Masters Business Admin |
| University of California San Diego | Doctorate Degree |
| Stony Brook University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 18 |
Operativa
| Director/Board Member | 7 |
| President | 5 |
| Chief Executive Officer | 4 |
Sectorial
| Health Technology | 13 |
| Consumer Services | 5 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| HARROW, INC. | Health Technology |
| ORAGENICS, INC. | Health Technology |
| MARKER THERAPEUTICS, INC. | Health Technology |
| GT BIOPHARMA, INC. | Health Technology |
| GENPREX, INC. | Health Technology |
| QRONS INC. | Health Technology |
| Empresas privadas | 7 |
|---|---|
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Microlin Bio, Inc. /Old/
 Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Health Technology |
Microlin Bio, Inc.
 Microlin Bio, Inc. Pharmaceuticals: MajorHealth Technology Microlin Bio, Inc. is a biopharmaceutical company, which engages in the development of micro ribonucleic, acid therapeutics. It offers programs for cancer therapeutics and delivery platform technology. The company was founded by Joseph Hernandez on January 27, 2013 and is headquartered in Daly City, CA. | Health Technology |
- Bolsa de valores
- Insiders
- John N. Bonfiglio
- Experiencia
